221 related articles for article (PubMed ID: 35435281)
1. Fatalities associated with gabapentinoids in England (2004-2020).
Kalk NJ; Chiu CT; Sadoughi R; Baho H; Williams BD; Taylor D; Copeland CS
Br J Clin Pharmacol; 2022 Aug; 88(8):3911-3917. PubMed ID: 35435281
[TBL] [Abstract][Full Text] [Related]
2. Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland.
Torrance N; Veluchamy A; Zhou Y; Fletcher EH; Moir E; Hebert HL; Donnan PT; Watson J; Colvin LA; Smith BH
Br J Anaesth; 2020 Aug; 125(2):159-167. PubMed ID: 32571568
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of and Factors Associated with Gabapentinoid Use and Misuse Among Texas Medicaid Recipients.
Ibiloye EA; Barner JC; Lawson KA; Rascati KL; Evoy KE; Peckham AM
Clin Drug Investig; 2021 Mar; 41(3):245-253. PubMed ID: 33580482
[TBL] [Abstract][Full Text] [Related]
4. Pregabalin and gabapentin in non-opioid poisoning deaths.
Kriikku P; Ojanperä I
Forensic Sci Int; 2021 Jul; 324():110830. PubMed ID: 34000615
[TBL] [Abstract][Full Text] [Related]
5. Gabapentinoids in Ireland 2010 to 2020: An observational study of trends in gabapentinoid prescribing, law enforcement drug seizures and postmortem toxicology.
Durand L; O'Kane A; Tierney J; Cronly M; Bennett KE; Kavanagh Y; Keenan E; Cousins G
Br J Clin Pharmacol; 2024 Apr; 90(4):987-995. PubMed ID: 38072974
[TBL] [Abstract][Full Text] [Related]
6. Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update.
Evoy KE; Sadrameli S; Contreras J; Covvey JR; Peckham AM; Morrison MD
Drugs; 2021 Jan; 81(1):125-156. PubMed ID: 33215352
[TBL] [Abstract][Full Text] [Related]
7. Gabapentinoid misuse, abuse and non-prescribed obtainment in a United States general population sample.
Evoy KE; Covvey JR; Peckham AM; Reveles KR
Int J Clin Pharm; 2021 Aug; 43(4):1055-1064. PubMed ID: 33387188
[TBL] [Abstract][Full Text] [Related]
8. Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance.
Tambon M; Ponté C; Jouanjus E; Fouilhé N; Micallef J; Lapeyre-Mestre M;
Front Psychiatry; 2021; 12():639780. PubMed ID: 33613345
[No Abstract] [Full Text] [Related]
9. Medicines associated with dependence or withdrawal: a mixed-methods public health review and national database study in England.
Marsden J; White M; Annand F; Burkinshaw P; Carville S; Eastwood B; Kelleher M; Knight J; O'Connor R; Tran A; Willey P; Greaves F; Taylor S
Lancet Psychiatry; 2019 Nov; 6(11):935-950. PubMed ID: 31588045
[TBL] [Abstract][Full Text] [Related]
10. Gabapentinoid Pharmacology in the Context of Emerging Misuse Liability.
Evoy KE; Peckham AM; Covvey JR; Tidgewell KJ
J Clin Pharmacol; 2021 Aug; 61 Suppl 2():S89-S99. PubMed ID: 34396549
[TBL] [Abstract][Full Text] [Related]
11. Opioid and gabapentinoid prescriptions in England from 2015 to 2020.
Xia Y; Forget P
PLoS One; 2022; 17(11):e0276867. PubMed ID: 36441772
[TBL] [Abstract][Full Text] [Related]
12. A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency's 'Suspected Adverse Drug Reactions' Database.
Chiappini S; Schifano F
CNS Drugs; 2016 Jul; 30(7):647-54. PubMed ID: 27312320
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of fatal gabapentinoid-related poisoning in Australia, 2000-2020.
Darke S; Duflou J; Peacock A; Farrell M; Lappin J
Clin Toxicol (Phila); 2022 Mar; 60(3):304-310. PubMed ID: 34402696
[TBL] [Abstract][Full Text] [Related]
14. Dose-Dependent Association of Gabapentinoids with Pulmonary Complications After Total Hip and Knee Arthroplasties.
Ohnuma T; Raghunathan K; Moore S; Setoguchi S; Ellis AR; Fuller M; Whittle J; Pyati S; Bryan WE; Pepin MJ; Bartz RR; Haines KL; Krishnamoorthy V
J Bone Joint Surg Am; 2020 Feb; 102(3):221-229. PubMed ID: 31804238
[TBL] [Abstract][Full Text] [Related]
15. [On the risk of dependence on gabapentinoids].
Bonnet U; Scherbaum N
Fortschr Neurol Psychiatr; 2018 Feb; 86(2):82-105. PubMed ID: 29179227
[TBL] [Abstract][Full Text] [Related]
16. How addictive are gabapentin and pregabalin? A systematic review.
Bonnet U; Scherbaum N
Eur Neuropsychopharmacol; 2017 Dec; 27(12):1185-1215. PubMed ID: 28988943
[TBL] [Abstract][Full Text] [Related]
17. Gabapentinoid Dosing and Associated Toxicities in Patients With or Without Concomitant Opioids During Hospitalization.
Tu TG; Sadeghi S; Atayee R; Lee K
Am J Hosp Palliat Care; 2022 May; 39(5):530-534. PubMed ID: 34409886
[TBL] [Abstract][Full Text] [Related]
18. Abuse and Misuse of Pregabalin and Gabapentin.
Evoy KE; Morrison MD; Saklad SR
Drugs; 2017 Mar; 77(4):403-426. PubMed ID: 28144823
[TBL] [Abstract][Full Text] [Related]
19. Trends in Gabapentin and Pregabalin Prescribing in a Tertiary Pediatric Medical Center.
Donado C; Nedeljkovic K; Wangnamthip S; Solodiuk JC; Bourgeois FT; Berde CB
Hosp Pediatr; 2021 Aug; 11(8):909-914. PubMed ID: 34257145
[TBL] [Abstract][Full Text] [Related]
20. Misuse and abuse of pregabalin and gabapentin: cause for concern?
Schifano F
CNS Drugs; 2014 Jun; 28(6):491-6. PubMed ID: 24760436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
